Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2024-01-24 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2024年第一次临时股东大会会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 2024 first extraordinary general meeting of shareholders of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes information about the meeting's convening, attendance, agenda items, voting results, and legal opinions on the meeting's validity. The content focuses on shareholder meeting decisions, voting outcomes, and procedural compliance. There is no indication that this is a full annual or interim report, audit report, earnings release, or other financial report. Instead, it is a formal announcement of the voting results and resolutions from a shareholders' meeting. The document length is 4226 characters, which is relatively short and typical for a voting results announcement. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-01-24 Chinese
北京大成（成都）律师事务所关于四川千里倍益康医疗科技股份有限公司2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm (Dentons) regarding the legality and validity of the procedures, attendance, and voting results of the 2024 first extraordinary general meeting (临时股东大会) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. This type of document is a legal opinion related to shareholder meeting proceedings and voting results, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4793 characters, and it is not a mere announcement of a report but a substantive legal opinion on the voting results and meeting procedures. Therefore, the best fitting classification is DVA.
2024-01-24 Chinese
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is an investor relations activity record from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details a specific investor relations event held on January 18, 2024, including participants, questions asked, and company responses. The content focuses on company strategy, product development, and market positioning rather than financial statements or regulatory filings. The document length is 1806 characters, which is relatively short and does not contain financial data or formal report content. It is not an earnings release, annual report, or any formal financial filing. It is also not a proxy statement, voting result, or management change announcement. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement related to investor relations activities that does not fit into other specific categories.
2024-01-21 Chinese
关于更换持续督导保荐代表人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the replacement of the continuous supervision sponsor representative for a company listed on the Beijing Stock Exchange. It details the change in personnel responsible for ongoing sponsor duties and includes a brief biography of the new representative. There is no financial data, report, or detailed analysis presented. The document is a formal announcement about management changes related to sponsorship and supervision roles, which aligns with Board/Management Information filings. The document length is short (1025 characters), and it is not a report or financial statement but an announcement of a change in company representatives.
2024-01-15 Chinese
关于公司2024年度使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the company's plan to use idle funds to purchase financial products in 2024. It details the purpose, amount, method, duration, decision-making process, risk analysis, and impact on the company. The document is relatively short (1330 characters) and serves as a formal public notice about financing activities rather than a detailed financial report or audit. It does not contain financial statements or detailed financial data but rather informs shareholders and the public about the company's capital management strategy. This fits the definition of a Capital/Financing Update (CAP).
2024-01-09 Chinese
关于预计2024年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2024. It includes details about the nature of the transactions, the parties involved, the decision-making and approval process by the board, and the opinion of the sponsoring institution. The document does not contain actual financial statements or detailed financial performance data. It is a regulatory announcement about anticipated related party transactions rather than a full financial report or management discussion. The document length is short (1995 characters), and it is a formal disclosure of expected transactions, fitting the category of a general regulatory announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-01-09 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.